By gavaging B. animalis and butyrate (separately) to a cancer preclinical mouse model and noticing anticancer effects, we proved that the anticancer effect of GpS is partly through stimulating the growth of beneficial bacteria in the gut (Liao et al., 2020). The gene discussed is NBEAL2; the disease is cancer.